Recent Updates
Recently added Catalysts
ZLAB

Vertex Announces Key Advancements Across Kidney Portfolio

Thursday, September 25, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Vertex Announces Key Advancements Across Kidney Portfolio
Price reaction · baseline $32.49 (2025-09-24 close) · hit after-hours · 1 other ZLAB headline(s) in the window, move may be shared
day 0 close · peak
-2.6%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer

Full Press Release Details

Vertex Announces Key Advancements Across Kidney Portfolio.
ShareAdd on Google
Tags: ZLAB Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Sep 25, 2025

Biotech snapshot

Cash runway
$618M liquidity · $21M/mo burn
~28 mo
Low dilution risk
Lead asset
ZL-1310Phase 3
Small-cell Lung Cancer →

Catalyst track record

+60%
best trade around ZLAB's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ZLAB.

See every catalyst's timing & PoA →